WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
The U.S. government, faced with a diminished drug-development pipeline in the private sector, is starting its own federal drug development center. The National Center for Advancing Translational Sciences will receive $1 billion in funding to conduct drug research, with the goal of attracting private investors.
In the past, the National Institutes of Health have usually focused on basic research. But the new science center might take discovery a step further, testing new chemicals in animals or even in human trials.